Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-coagulation factor XI antibodies

Anti-coagulation factor XI antibodies

US Patent 11485794 · Granted Nov 1, 2022

Estimated economic value: $448,368,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Establishing sessions via a proxy service2025
Human PD-L2 antibodies and methods of use therefor2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Anti-IL-27 antibodies and uses thereof2025
CD38 modulating antibody agents2025
Human PD-L1 antibodies and methods of use therefor2025
Factor XI activation inhibitors2025
CD38 modulating antibody2025
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of 2025
Anti-coagulation factor XI antibodies2025